R K Shockley
Overview
Explore the profile of R K Shockley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Payne Jr W, Marshall D, Shockley R, Martin W
Clin Microbiol Rev
. 1988 Jul;
1(3):313-29.
PMID: 3058298
Monoclonal antibody (MAb) technology is well recognized as a significant development for producing specific serologic reagents to a wide variety of antigens in unlimited amounts. These reagents have provided the...
2.
Jay W, Shockley R
J Ocul Pharmacol
. 1988 Jan;
4(4):345-9.
PMID: 3246569
We delineated the dose- and time-dependent retinal toxicity of cefepime (BMY-28142), a new third generation cephalosporin, using electroretinography in pigmented rabbit eyes. Toxicity was evaluated following intravitreal doses ranging from...
3.
Rissing J, Buxton T, HORNER J, Shockley R, Fisher J, Harris R
J Lab Clin Med
. 1987 Oct;
110(4):433-8.
PMID: 3655522
We explored the potential role of microbial synergy in an experimental rat osteomyelitis model. Osteomyelitis was assessed by gross pathologic conditions and quantitative cultivation of rat tibiae for the implanted...
4.
Jay W, Fishman P, Aziz M, Shockley R
J Ocul Pharmacol
. 1987 Jan;
3(3):257-62.
PMID: 3332679
We delineated the dose-and time-dependent retinal toxicity of intravitreal ceftazidime using electroretinography (ERG) in phakic rabbit eyes. Toxicity was evaluated following intravitreal doses ranging from 0.5 to 50 mg/0.1 ml....
5.
Shockley R, Fishman P, Aziz M, Yannis R, Jay W
Arch Ophthalmol
. 1986 Feb;
104(2):266-8.
PMID: 3511898
The ocular kinetics of ceftazidime, a third-generation cephalosporin, were examined in phakic and aphakic pigmented eyes of rabbits following subconjunctival injection (100 mg). Peak ceftazidime concentrations (mean +/- SE, n...
6.
Yannis R, Rissing J, Buxton T, Shockley R
Am J Ophthalmol
. 1985 Sep;
100(3):404-7.
PMID: 3898852
We compared subconjunctivally administered ceftazidime and BMY 28142, two third-generation cephalosporins, to a regimen of gentamicin and cefazolin for their ability to prevent experimental Pseudomonas postoperative endophthalmitis in rabbits. After...
7.
Rissing J, Buxton T, Fisher J, Harris R, Shockley R
Infect Immun
. 1985 Jul;
49(1):141-4.
PMID: 3924826
Arachidonic acid was used as a facilitating agent in experimental rat Staphylococcus aureus osteomyelitis and compared with the more commonly used agent, sodium morrhuate. The injection of arachidonic acid or...
8.
Rissing J, Buxton T, Weinstein R, Shockley R
Infect Immun
. 1985 Mar;
47(3):581-6.
PMID: 3972440
We describe here a Sprague-Dawley rat model for chronic osteomyelitis. Staphylococcus aureus and sodium morrhuate were implanted by either microdrilling or direct needle injection into the tibiae of rats. Of...
9.
Shockley R, Jay W, Fishman P, Aziz M, Rissing J
Acta Ophthalmol (Copenh)
. 1985 Feb;
63(1):35-8.
PMID: 3873166
A reproducible animal model is necessary to examine the use of antimicrobial agents for prophylaxis and treatment of bacterial endophthalmitis. We determined the minimum inoculum size of S. aureus and...
10.
Jay W, Aziz M, Rissing J, Shockley R
Arch Ophthalmol
. 1985 Jan;
103(1):121-3.
PMID: 3977664
Ocular toxic effects of intravitreally injected ceftriaxone sodium and its rate of clearance after a single dose were studied in rhesus and cynomolgus monkeys. Doses of 2, 2.5, and 3...